Inhibiting TGFβ signaling restores the ECM, regulates tumor vasculature, reverses epithelial-mesenchymal transition (EMT), damages cancer stem cells, and can enhance the response to chemotherapy (30, 31). Here, TGFB1 is linked to neoplasm.